PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21537887-10	2012	Treatment of bCSC with CAPE (4.5-days) decreased CD44 levels by 95%, while another cell population containing 10-100-fold lower CD44 content concurrently increased.	caffeic acid phenethyl ester	23-27	CD44 molecule (Indian blood group)	Homo sapiens	49-53	
21537887-11	2012	Results suggest that CAPE causes pronounced changes in bCSC characteristics manifested by inhibition of self renewal, progenitor formation, clonal growth in soft agar, and concurrent significant decrease in CD44 content, all signs of decreased malignancy potential.	caffeic acid phenethyl ester	21-25	CD44 molecule (Indian blood group)	Homo sapiens	207-211